Oracle's (ORCL) Neutral Rating Reiterated at Piper Sandler

Piper Sandler reiterated their neutral rating on shares of Oracle (NYSE:ORCL - Free Report) in a research report sent to investors on Wednesday,Benzinga reports. The brokerage currently has a $130.00 price objective on the enterprise software provider's stock.

Other analysts have also issued reports about the stock. Barclays dropped their target price on shares of Oracle from $212.00 to $202.00 and set an "overweight" rating for the company in a report on Tuesday, March 11th. JPMorgan Chase & Co. lowered their price objective on shares of Oracle from $140.00 to $135.00 and set a "neutral" rating for the company in a report on Tuesday, March 11th. BMO Capital Markets raised their price objective on shares of Oracle from $175.00 to $200.00 and gave the stock a "market perform" rating in a report on Monday. DA Davidson lowered their price objective on shares of Oracle from $150.00 to $140.00 and set a "neutral" rating for the company in a report on Monday, April 14th. Finally, Mizuho lowered their price objective on shares of Oracle from $210.00 to $180.00 and set an "outperform" rating for the company in a report on Tuesday, April 15th. Twelve analysts have rated the stock with a hold rating, nineteen have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Oracle presently has a consensus rating of "Moderate Buy" and a consensus price target of $194.32.

Oracle Trading Up 7.8%

NYSE ORCL traded up $15.68 during trading on Wednesday, hitting $215.54. 53,639,099 shares of the company's stock traded hands, compared to its average volume of 9,727,788. The stock has a fifty day moving average of $152.88 and a two-hundred day moving average of $160.62. The company has a debt-to-equity ratio of 5.65, a current ratio of 0.81 and a quick ratio of 0.81. Oracle has a 12-month low of $118.86 and a 12-month high of $216.60. The firm has a market cap of $602.86 billion, a P/E ratio of 52.70, a PEG ratio of 3.46 and a beta of 1.32.

Oracle (NYSE:ORCL - Get Free Report) last posted its quarterly earnings results on Wednesday, June 11th. The enterprise software provider reported $1.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.64 by $0.06. The business had revenue of $15.90 billion during the quarter, compared to analyst estimates of $15.58 billion. Oracle had a net margin of 21.16% and a return on equity of 133.25%. The company's revenue was up 11.3% on a year-over-year basis. During the same period in the prior year, the business posted $1.63 earnings per share. As a group, sell-side analysts expect that Oracle will post 5 EPS for the current year.

Oracle Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, July 24th. Shareholders of record on Thursday, July 10th will be issued a $0.50 dividend. The ex-dividend date is Thursday, July 10th. This represents a $2.00 dividend on an annualized basis and a yield of 0.93%. Oracle's dividend payout ratio is currently 46.95%.

Insider Buying and Selling at Oracle

In related news, Vice Chairman Jeffrey Henley sold 400,000 shares of the company's stock in a transaction dated Thursday, June 12th. The shares were sold at an average price of $190.42, for a total transaction of $76,168,000.00. Following the transaction, the insider now directly owns 1,097,576 shares in the company, valued at approximately $209,000,421.92. This represents a 26.71% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Naomi O. Seligman sold 2,866 shares of the company's stock in a transaction dated Monday, May 5th. The shares were sold at an average price of $149.53, for a total transaction of $428,552.98. Following the transaction, the director now owns 31,764 shares in the company, valued at $4,749,670.92. The trade was a 8.28% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 427,366 shares of company stock worth $80,183,723. Insiders own 42.20% of the company's stock.

Institutional Investors Weigh In On Oracle

Several large investors have recently added to or reduced their stakes in the stock. Cookson Peirce & Co. Inc. boosted its position in Oracle by 4.4% in the 4th quarter. Cookson Peirce & Co. Inc. now owns 1,423 shares of the enterprise software provider's stock valued at $237,000 after buying an additional 60 shares during the period. Warther Private Wealth LLC lifted its position in shares of Oracle by 1.8% in the 4th quarter. Warther Private Wealth LLC now owns 3,621 shares of the enterprise software provider's stock worth $603,000 after purchasing an additional 63 shares during the period. Howard Bailey Securities LLC lifted its position in shares of Oracle by 2.9% in the 4th quarter. Howard Bailey Securities LLC now owns 2,274 shares of the enterprise software provider's stock worth $379,000 after purchasing an additional 64 shares during the period. New England Capital Financial Advisors LLC lifted its position in shares of Oracle by 6.4% in the 4th quarter. New England Capital Financial Advisors LLC now owns 1,061 shares of the enterprise software provider's stock worth $177,000 after purchasing an additional 64 shares during the period. Finally, Cape ANN Savings Bank lifted its position in Oracle by 1.1% during the fourth quarter. Cape ANN Savings Bank now owns 5,820 shares of the enterprise software provider's stock valued at $970,000 after acquiring an additional 65 shares during the last quarter. 42.44% of the stock is owned by hedge funds and other institutional investors.

About Oracle

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.